AU8023000B2 - - Google Patents

Info

Publication number

AU8023000B2

AU8023000B2 AU8023000B2 AU 8023000 B2 AU8023000 B2 AU 8023000B2 AU 8023000 B2 AU8023000 B2 AU 8023000B2

Authority

AU

Australia

Prior art keywords

hyaff

composition

rhbmp

hyaluronic acid

gel

Prior art date

2004-06-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 claims description 46
• 108090000623 proteins and genes Proteins 0.000 claims description 42
• 102000004169 proteins and genes Human genes 0.000 claims description 42
• QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 38
• 239000001506 calcium phosphate Substances 0.000 claims description 38
• 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 38
• 229940078499 tricalcium phosphate Drugs 0.000 claims description 38
• 235000019731 tricalcium phosphate Nutrition 0.000 claims description 38
• 230000002188 osteogenic Effects 0.000 claims description 34
• 239000011148 porous material Substances 0.000 claims description 24
• 229920002674 hyaluronan Polymers 0.000 claims description 16
• 229960003160 hyaluronic acid Drugs 0.000 claims description 16
• MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical class [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims description 16
• 150000002148 esters Chemical class 0.000 claims description 12
• -1 hyaluronic acid ester Chemical class 0.000 claims description 7
• 239000003960 organic solvent Substances 0.000 claims description 6
• 239000012062 aqueous buffer Substances 0.000 claims description 4
• 239000011159 matrix material Substances 0.000 claims description 4
• 101700000123 BMP2 Proteins 0.000 claims description 3
• 102100005377 BMP2 Human genes 0.000 claims description 3
• 241000722985 Fidia Species 0.000 claims description 2
• 229920001222 biopolymer Polymers 0.000 claims description 2
• 230000002068 genetic Effects 0.000 claims 1
• 239000000499 gel Substances 0.000 description 64
• 235000018102 proteins Nutrition 0.000 description 34
• 210000000988 Bone and Bones Anatomy 0.000 description 29
• 239000000969 carrier Substances 0.000 description 23
• UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 17
• 229920001223 polyethylene glycol Polymers 0.000 description 17
• 230000014759 maintenance of location Effects 0.000 description 13
• 230000011164 ossification Effects 0.000 description 10
• 239000007787 solid Substances 0.000 description 10
• 238000007792 addition Methods 0.000 description 9
• 241000283973 Oryctolagus cuniculus Species 0.000 description 8
• 238000000338 in vitro Methods 0.000 description 8
• 206010017076 Fracture Diseases 0.000 description 7
• 241000700159 Rattus Species 0.000 description 7
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 239000007972 injectable composition Substances 0.000 description 6
• 229920000642 polymer Polymers 0.000 description 6
• 230000000717 retained Effects 0.000 description 6
• 230000003115 biocidal Effects 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
• 235000017557 sodium bicarbonate Nutrition 0.000 description 5
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
• 230000037177 Biodistribution Effects 0.000 description 4
• 210000000845 Cartilage Anatomy 0.000 description 4
• 210000002966 Serum Anatomy 0.000 description 4
• 208000009880 Ulna Fractures Diseases 0.000 description 4
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000000034 method Methods 0.000 description 4
• 238000002156 mixing Methods 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 239000000700 tracer Substances 0.000 description 4
• 206010022114 Injury Diseases 0.000 description 3
• 239000002202 Polyethylene glycol Substances 0.000 description 3
• 210000000623 Ulna Anatomy 0.000 description 3
• 238000004166 bioassay Methods 0.000 description 3
• 210000004027 cells Anatomy 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 230000036571 hydration Effects 0.000 description 3
• 238000006703 hydration reaction Methods 0.000 description 3
• 239000007943 implant Substances 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000006011 modification reaction Methods 0.000 description 3
• SECXISVLQFMRJM-UHFFFAOYSA-N n-methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 229940064005 Antibiotic throat preparations Drugs 0.000 description 2
• 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 2
• 229940042052 Antibiotics for systemic use Drugs 0.000 description 2
• 229940042786 Antitubercular Antibiotics Drugs 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N Benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 208000003044 Closed Fractures Diseases 0.000 description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
• 229940093922 Gynecological Antibiotics Drugs 0.000 description 2
• 206010031252 Osteomyelitis Diseases 0.000 description 2
• CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 2
• 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 2
• MYPYJXKWCTUITO-LYRMYLQWSA-N VANCOMYCIN Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
• 229960003165 Vancomycin Drugs 0.000 description 2
• 108010059993 Vancomycin Proteins 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 230000002146 bilateral Effects 0.000 description 2
• 238000006065 biodegradation reaction Methods 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 235000012970 cakes Nutrition 0.000 description 2
• OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Inorganic materials [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
• ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 description 2
• 230000022159 cartilage development Effects 0.000 description 2
• 201000009910 diseases by infectious agent Diseases 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 229940079593 drugs Drugs 0.000 description 2
• 230000001605 fetal Effects 0.000 description 2
• 238000005755 formation reaction Methods 0.000 description 2
• 239000011507 gypsum plaster Substances 0.000 description 2
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 229940079866 intestinal antibiotics Drugs 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 239000004310 lactic acid Substances 0.000 description 2
• 235000014655 lactic acid Nutrition 0.000 description 2
• 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 2
• 230000002138 osteoinductive Effects 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 238000005063 solubilization Methods 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000005720 sucrose Substances 0.000 description 2
• 230000001131 transforming Effects 0.000 description 2
• 210000001909 Alveolar Process Anatomy 0.000 description 1
• 108020004491 Antisense DNA Proteins 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 101700046223 BMP1 Proteins 0.000 description 1
• 102100007313 BMP1 Human genes 0.000 description 1
• 208000009755 Bone Cysts Diseases 0.000 description 1
• 208000003432 Bone Disease Diseases 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 229920002676 Complementary DNA Polymers 0.000 description 1
• JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 241000289669 Erinaceus europaeus Species 0.000 description 1
• 210000003414 Extremities Anatomy 0.000 description 1
• 229960002989 Glutamic Acid Drugs 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• 210000003041 Ligaments Anatomy 0.000 description 1
• 102100020304 OPLAH Human genes 0.000 description 1
• 101710022750 OPLAH Proteins 0.000 description 1
• 229920000272 Oligonucleotide Polymers 0.000 description 1
• 241000906034 Orthops Species 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 102000007312 Recombinant Proteins Human genes 0.000 description 1
• 108010033725 Recombinant Proteins Proteins 0.000 description 1
• 210000002435 Tendons Anatomy 0.000 description 1
• 241000897276 Termes Species 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000003816 antisense DNA Substances 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 230000003416 augmentation Effects 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 229960005188 collagen Drugs 0.000 description 1
• 239000000515 collagen sponge Substances 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 239000002131 composite material Substances 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 229920003013 deoxyribonucleic acid Polymers 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 230000001747 exhibiting Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 150000004676 glycans Polymers 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 229960000890 hydrocortisone Drugs 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 230000010874 maintenance of protein location Effects 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 235000010755 mineral Nutrition 0.000 description 1
• 230000001089 mineralizing Effects 0.000 description 1
• 230000000921 morphogenic Effects 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 230000000790 osteoblast Effects 0.000 description 1
• 230000001009 osteoporotic Effects 0.000 description 1
• 230000003239 periodontal Effects 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 150000004804 polysaccharides Polymers 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 230000002035 prolonged Effects 0.000 description 1
• 230000029983 protein stabilization Effects 0.000 description 1
• 239000002510 pyrogen Substances 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 238000004626 scanning electron microscopy Methods 0.000 description 1
• 239000003352 sequestering agent Substances 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 231100000803 sterility Toxicity 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 230000002459 sustained Effects 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 210000001519 tissues Anatomy 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1